Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gimatecan in previously treated small cell lung cancer
NCT04501029Phase 2Unknown
- Sponsor
- Lee's Pharmaceutical Holdings Limited
- Start
- Oct 2020
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gimatecan in small cell lung cancer (SCLC), sponsored by Lee's Pharmaceutical Holdings Limited. Status: unknown.
02
Drugs
gimatecan
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT04501029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04501029.